Human Leukocyte Antigen-A*02:01-restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer

NCT00683085 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Lack of eligible patient

Conditions

Pancreatic Cancer
Pancreas Neoplasms

Interventions

BIOLOGICAL: HLA-A*02:01-restricted VEGFR1-derived peptide vaccination

Sponsor

Tokyo University

Collaborators

[object Object]